Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$15.06 - $30.65 $128,868 - $262,272
-8,557 Closed
0 $0
Q1 2022

Apr 28, 2022

BUY
$23.26 - $42.41 $47,078 - $85,837
2,024 Added 30.98%
8,557 $250,000
Q4 2021

Jan 25, 2022

BUY
$37.54 - $57.51 $3,829 - $5,866
102 Added 1.59%
6,533 $277,000
Q3 2021

Oct 27, 2021

SELL
$45.91 - $59.67 $1,515 - $1,969
-33 Reduced 0.51%
6,431 $320,000
Q2 2021

Aug 10, 2021

BUY
$43.3 - $67.17 $44,555 - $69,117
1,029 Added 18.93%
6,464 $379,000
Q1 2021

Apr 28, 2021

BUY
$44.11 - $90.64 $239,737 - $492,628
5,435 New
5,435 $318,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $340M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Spearhead Capital Advisors, LLC Portfolio

Follow Spearhead Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.